Biospecifics Technologies (BSTC) Reports Q4 EPS of $0.36

Biospecifics Technologies (NASDAQ: BSTC) reported Q4 EPS of $0.36, versus $27.00 reported last year. Revenue for the quarter came in at $6.1 million, versus $4.6 million reported last year.

For earnings history and earnings-related data on Biospecifics Technologies (BSTC) click here.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• UBS says bull market has further to run
• Why this strategist thinks longer-term outlook for stocks is "unfavorable"